openPR Logo
Press release

Gene Therapy and Antisense Drugs Market – Global Industry Demand, Growth, Prize and Business Forecast by 2025

09-15-2017 09:04 AM CET | Health & Medicine

Press release from: TMR Research

Gene Therapy and Antisense Drugs Market – Global Industry

Global Gene Therapy and Antisense Drugs Market: Snapshot

Since an escalating number of patients are being diagnosed with cancer every day, the global demand for gene therapy and antisense drugs is bound to multiply. The growing incidence of health conditions such as Parkinson’s disease and high cholesterol is also boosting the demand for gene therapy and antisense drugs. Several new drugs and therapies have been making their debut in the global gene therapy and antisense drugs market of recent.

For instance, in June 2017, it was announced that a group of scientists at the University of Queensland have developed a new technique that is capable of permanently silencing severe allergies triggered by shellfish, peanuts, and venom. The treatment was found to be successful in animal trials. The technique holds considerable potential for treating asthma completely. During the same month, results of another research study for treating multiple myeloma, a type of blood cancer, were announced at a conference held by the American Society of Clinical Oncology. The new CAR-T therapy consists of filtering the blood of the patients in order to eliminate T cells which are then genetically altered and given back to the patients.

Request Sample Copy of the Report @ www.tmrresearch.com/sample/sample?flag=B&rep_id=500

However, the difficulty pertaining to the delivery of antisense technology to the brain can present key challenges to the expansion of the global market for gene therapy and antisense drugs. Moreover, the unavoidable toxic aftereffects associated with the technology can also inhibit the growth of the gene therapy and antisense drugs market worldwide. However, the present attempts at developing safe and efficient antisense drugs by several market participants including Ionis Pharmaceuticals, which undertook testing of the technology on transgenic mice, can promote the further expansion of the market.

Global Gene Therapy and Antisense Drugs Market: Overview

Antisense gene therapy is emerging as one of the most beneficial therapeutics for various diseases such as tumors, cancer etc. These newer therapies are based on increased knowledge of molecular events that lead to disordered cellular growth. The therapy involves using a gene silencing technique rather than a gene repairing technique for silencing the gene’s effect.

The research report is a valuable tool for comprehending the progression of the global gene therapy and antisense drugs market between 2017 and 2025.

Request TOC of the Report @ www.tmrresearch.com/sample/sample?flag=T&rep_id=500

Global Gene Therapy and Antisense Drugs Market: Treatment Insights

Antisense drugs attach to the mRNA of a target protein, which inhibits the protein production process. Antisense therapeutics can obstruct the expression of oncogenes and other cancer-related genes that express growth factors. Antisense gene therapy involves the utilization of various therapeutic strategies which requires a clear knowledge of the molecular anatomy of cancer related genes. Antisense gene therapy is used to treat various diseases such as hemorrhagic fever, cancer, cystic fibrosis, renal diseases, HIV/AIDS, spinal muscular atrophy, and cardiovascular diseases.

Global Gene Therapy and Antisense Drugs Market: Market Segmentation

On the basis of therapeutic area, the gene therapy and antisense drugs market is segmented into cancer, anemia, rheumatoid arthritis, cardiovascular diseases, HIV/AIDS, cystic fibrosis, diabetes mellitus and obesity, and renal diseases.

Request Discount of the Report @ www.tmrresearch.com/sample/sample?flag=D&rep_id=500

By gene transfer method, ex vivo gene transfer and in vivo gene transfer are the segments of the market. The former involves the transfer of cloned genes into cells, i.e., cells are altered outside the body before being implanted into the patient, whereas the latter involves the transfer of cloned genes directly into the patient’s tissues. The outcome of in vivo gene transfer technology mainly depends on the general efficacy of gene transfer and expression.

Global Gene Therapy and Antisense Drugs Market: Regional Outlook

The global gene therapy and antisense drugs market is segmented into North America, Asia Pacific, Europe, and Rest of the World. Amongst these, North America holds the leading position in the market followed by Europe. The increasing incidence of cancer and other fatal diseases, unhealthy lifestyle practices such as excessive smoking and excessive consumption of high fat content food, and increasing research efforts for treatment against cancer are the major factors driving the gene therapy and antisense drugs market in these regions.

Asia Pacific is expected to emerge as a significant market for gene therapy and antisense drugs. The high population density including a large geriatric population, expeditiously increasing demand for technologically advanced therapeutics, and increasing government support for improved healthcare infrastructure in the region is driving the growth of this regional market. Furthermore, favorable reimbursement policies and tax benefits on newer therapies will further fuel the growth of the Asia Pacific gene therapy and antisense drugs market.

Major Companies Mentioned in Report

Some of the leading companies operating in the global gene therapy and antisense drugs market are GenVec Inc., Avigen Inc., Genome Therapeutics Corp., Tekmira Pharmaceuticals Corporation, Isis Pharmaceuticals, Cell Genesys Inc., and others. These companies are profiled for their key business attributes in the report.

About TMR Research

TMR Research is a premier provider of customized market research and consulting services to business entities keen on succeeding in today’s supercharged economic climate. Armed with an experienced, dedicated, and dynamic team of analysts, we are redefining the way our clients’ conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends.

Our savvy custom-built reports span a gamut of industries such as pharmaceuticals, chemicals and metals, food and beverages, and technology and media, among others. With actionable insights uncovered through in-depth research of the market, we try to bring about game-changing success for our clients.

Contact:

Rohit Bhisey
Head - Internet Marketing
Tel: +1-415-520-1050
Email: sales@tmrresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Gene Therapy and Antisense Drugs Market – Global Industry Demand, Growth, Prize and Business Forecast by 2025 here

News-ID: 718829 • Views: 192

More Releases from TMR Research

Power Uprates Market Scope and Opportunities Analysis 2017 – 2025 | Lightbridg …
Global Power Uprates Market : Snapshot With escalating population across the world and rapid urbanization in several emerging economies, the demand for power it at an all-time peak. In this scenario, it becomes essential to increase the efficiency of each nuclear power plant. Power uprate is the technique with which not only the maximum heat output can be achieved, it does to in accordance to the plant safety. Get Sample Copy of
IoT Cloud Platform Market Segmentation Detailed Study with Forecast to 2025 | Se …
Global IoT cloud Platform Market: Snapshot The Internet of Things has emerged as a prominent platform for data and information sharing in the IT world. Within a short period of time it has gained popularity and is being used by a large population base. The inter-networking of physical devices, buildings, vehicles, and other items that have been integrated with network connectivity, actuators, software, sensors, and electronics, allowing the objects to accumulate
Smart Advisors Market Latest Trends and Future Growth Study by 2025 | IBM Watson
Global Smart Advisors Market: Snapshot There has been a significant rise in demand for demand for wealth advisory across the globe over the past few years, chiefly owing to the rising wealth of the affluent upper-middle class in emerging economies and the substantial increase in the number of high-net-worth individuals (HNWIs) globally. While financial advisory firms across the globe position themselves to benefit from the vast rise in growth opportunities, a
Cloud Computing in Education Market Share and Growth Factors Impact Analysis 201 …
Global Cloud Computing in Education Market: Snapshot As the rapidly expanding education sector faces sustainability issues and budget restrictions, cloud computing is increasingly being seen as one approach to relieve these pressures. As capacity requirements of an educational institution begin to fluctuate and as new services and applications become available, the association with cloud allows institutions to meet the needs of their constituents in a cost effective and quick manner. As

All 5 Releases


More Releases for Antisense

Antisense Oligonucleotides Market Global Trends, Analysis and Forecast 2027
Antisense oligonucleotides (ASOs) are 15–25 nt oligonucleotides designed to tie complementary RNA targets for the degradation. They are synthesized so that they can be used to block disease processes by altering the synthesis of a specific protein. ASOs offers promising treatment options for a range of medical disorders. They facilitate the development of therapeutics affecting protein targets which cannot be treated with protein therapeutics. They can target a particular malfunctioning
Antisense Oligonucleotides Market Outlook, and Opportunity Analysis, 2018 – 20 …
Antisense oligonucleotides are short, single stranded RNA or DNA molecules. Antisense oligonucleotides do not modulate the activity of already formed proteins, however they act before proteins are produced at the level of messenger RNA in the cell. Antisense oligonucleotides is used in treatment of oncology, Central nervous system therapeutics, inflammation therapeutics, diabetes, asthma, hair loss, etc. Antisense oligonucleotides is also used in genomics. Some examples of antisense nucleotides are fomivirsen
Antisense Oligonucleotides Market Opportunity Analysis, 2026
Antisense oligonucleotides are short, single stranded RNA or DNA molecules. Antisense oligonucleotides do not modulate the activity of already formed proteins, however they act before proteins are produced at the level of messenger RNA in the cell. Antisense oligonucleotides is used in treatment of oncology, Central nervous system therapeutics, inflammation therapeutics, diabetes, asthma, hair loss, etc. Antisense oligonucleotides is also used in genomics. Some examples of antisense nucleotides are fomivirsen
Gene Therapy and Antisense Drugs Market Highly Providential in 2025
Global Gene Therapy and Antisense Drugs Market: Snapshot Since an escalating number of patients are being diagnosed with cancer every day, the global demand for gene therapy and antisense drugs is bound to multiply. The growing incidence of health conditions such as Parkinson’s disease and high cholesterol is also boosting the demand for gene therapy and antisense drugs. Several new drugs and therapies have been making their debut in the global
Antisense Oligonucleotides Market to Record an Exponential CAGR by 2027
Antisense oligonucleotides (ASOs) are 15–25 nt oligonucleotides designed to tie complementary RNA targets for the degradation. They are synthesized so that they can be used to block disease processes by altering the synthesis of a specific protein. ASOs offers promising treatment options for a range of medical disorders. They facilitate the development of therapeutics affecting protein targets which cannot be treated with protein therapeutics. They can target a particular malfunctioning
Gene Therapy and Antisense Drugs Market - Forecast by 2017- 2025
Global Gene Therapy and Antisense Drugs Market: Snapshot Since an escalating number of patients are being diagnosed with cancer every day, the global demand for gene therapy and antisense drugs is bound to multiply. The growing incidence of health conditions such as Parkinson’s disease and high cholesterol is also boosting the demand for gene therapy and antisense drugs. Several new drugs and therapies have been making their debut in the global